Prognostic implications of mismatch repair deficiency in patients with nonmetastatic colorectal and endometrial cancer

被引：33

作者：

Fountzilas, Elena ^{[1
]}

Kotoula, Vassilici ^{[2
,3
]}

Pentheuudakis, George ^{[4
]}

Manousou, Kydaki ^{[5
]}

Polychronidou, Genovefa ^{[6
]}

Vrettou, Etent ^{[2
]}

Paulios, Christos ^{[2
]}

Papadopoulou, Drina ^{[7
]}

Raptou, Georgia ^{[2
]}

Pectasides, Eirini ^{[8
,9
]}

Karayannopoulou, Georgia ^{[2
]}

Chrisafi, Sofia ^{[3
]}

Papakostas, Davies ^{[10
]}

Makatsoris, Thomas ^{[11
]}

Varthalitis, Ioannis ^{[12
]}

Psyrri, Amanda ^{[13
]}

Samantas, Epaminontas ^{[14
]}

Bobos, Mattheos ^{[3
]}

Christodoulou, Christos ^{[15
]}

Papacimitriou, Christos ^{[16
]}

Nasiculas, George ^{[7
]}

Pechasides, Dimitrios ^{[17
]}

Fountzilas, George ^{[18
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Houston, TX 77030 USA

[2] Aristotle Univ Thessaloniki, Sch Hlth Sci, Fac Med, Dept Pathol, Thessaloniki, Greece

[3] Aristotle Univ Thessaloniki, Hellen Fdn Canc Res, Lab Mol Oncol, Thessaloniki, Greece

[4] Univ Ioannina, Dept Med Oncol, Ioannina, Greece

[5] Hellen Cooperat Oncol Grp, Data Off, Sect Biostat, Athens, Greece

[6] Aristotle Univ Thessaloniki, Sch Hlth Sci, Fac Med, Dept Med Oncol,Papageorglou Hosp, Thessaloniki, Greece

[7] GeneKor Med SA, Athens, Greece

[8] Beth Israel Deaconess Med Ctr, Dept Med, Div Hematol & Oncol, Boston, MA 02215 USA

[9] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA

[10] Hippokrateion Hosp, Oncol Unit, Athens, Greece

[11] Univ Patras, Med Sch, Univ Hosp, Dept Med,Div Oncol, Patras, Greece

[12] Gen Hosp Chania, Oncol Dept, Khania, Greece

[13] Natl & Kapodistrian Univ Athens, Sch Med, Attikon Univ Hosp, Sect Med Oncol,Dept Internal Med,Fac Med, Athens, Greece

[14] AgiiAnargiri Canc Hosp, Dept Med Oncol 3, Athens, Greece

[15] Metropolitan Hosp, Dept Med Oncol 2, Piraeus, Greece

[16] Natl & Kapodistrian Univ Athens, Sch Med, Alexandra Hosp, Dept Clin Therapeut, Athens, Greece

[17] Hippokrateion Hosp, Dept Internal Med 2, Oncol Sect, Athens, Greece

[18] Aristotle Univ Thessaloniki, Thessaloniki, Greece

来源：

ESMO OPEN | 2019年 / 4卷 / 02期

关键词：

III COLON-CANCER; RANDOMIZED PHASE-III; MICROSATELLITE-INSTABILITY; ADJUVANT CHEMOTHERAPY; RECTAL-CANCER; CLINICOPATHOLOGICAL SIGNIFICANCE; PD-1; BLOCKADE; BRAF MUTATION; FLUOROURACIL; LEUCOVORIN;

D O I：

10.1136/esmoopen-2018-000474

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Background The clinical relevance of mismatch repair (MMR) status in patients with nonmetastatic cancer across tumour types remains unclear. Our goal was to investigate the prognostic role of MMR deficiency in patients with stage I-III colorectal and endometrial cancer. Methods Patients with nonmetastatic colorectal and endometrial cancer with tumour tissue available for analysis were identified through the Hellenic Cooperative Oncology Group (HeCOG)'s tumour repository. Patients had been referred to Departments of Medical Oncology affiliated with HeCOG. MMR protein expression was evaluated by immunohistochemistry. The primary outcome measure was overall survival (OS). Results From May 1990 to September 2012, 1158 patients with nonmetastatic colorectal (N = 991) and endometrial cancer (N = 167) were identified (median age: 64 years, men: 544). All patients with colorectal and 109 (65%) with endometrial cancer had received adjuvant treatment. MMR deficiency was observed in 114 (11.5%) of colorectal and 80 (47.9%) of endometrial tumours. More commonly deficient proteins were PMS2 (69 patients, 7%) and MLH1 (63 patients, 6.5%) in colorectal cancer and MSH2 (58 patients, 34.7%) in endometrial cancer. Colorectal MMR-deficient (dMMR) tumours were more likely to be right sided (65 % dMMR vs 27 % proficient MMR, pMMR; p < 0.001), high grade (31% vs 15%, chi(2), p < 0.001) and with a mucinous component (64% vs 42%, p < 0.001). Endometrial dMMR tumours were more often of endometrioid histology (51.4 % endometrioid vs 20 % serous/clear cell, p = 0.020). Compared with MMR proficiency, MMR deficiency was associated with improved OS in patients with endometrial cancer (HR = 0.38, 95% CI 0.20 to 0.76, p = 0.006), but not in patients with colorectal cancer (HR = 0.73, 95% CI 0.49 to 1.09, p = 0.130). After adjusting for age, stage and grade, MMR deficiency maintained its favourable prognostic significance in patients with endometrial cancer (HR = 0.42, 95% CI 0.20 to 0.88, p = 0.021). Conclusions DMMR was associated with improved outcomes in patients with nonmetastatic endometrial cancer, but not in patients with nonmetastatic colorectal cancer who received adjuvant chemotherapy.

引用

页数：10

共 79 条

[51] Association between mismatch repair gene and irinotecan-based chemotherapy in metastatic colon cancer [J].

Ma, Junli ;

Zhang, Yan ;

Shen, Hong ;

Kapesa, Linda ;

Liu, Wenqiang ;

Zeng, Mengsi ;

Zeng, Shan .

TUMOR BIOLOGY, 2015, 36 (12) :9599-9609

[52]

MacDonald ND, 2000, CANCER RES, V60, P1750

[53] Prognostic value of microsatellite instability (MSI) and PTEN expression in women with endometrial cancer: Results from studies of the NCIC Clinical Trials Group (NCIC CTG) [J].

Mackay, Helen J. ;

Gallinger, Steven ;

Tsao, Ming S. ;

McLachlin, C. Meg ;

Tu, Dongsheng ;

Keiser, Katharina ;

Eisenhauer, Elizabeth A. ;

Oza, Amit M. .

EUROPEAN JOURNAL OF CANCER, 2010, 46 (08) :1365-1373

[54] Cellular effects of CPT-11 on colon carcinoma cells:: Dependence on p53 and hMLH1 status [J].

Magrini, R ;

Bhonde, MR ;

Hanski, RL ;

Notter, M ;

Scherübl, H ;

Boland, CR ;

Zeitz, M ;

Hanski, C .

INTERNATIONAL JOURNAL OF CANCER, 2002, 101 (01) :23-31

[55]

McCracken J, 2018, CAP TODAY AMP CASE R

[56] Reliable Pan-Cancer Microsatellite Instability Assessment by Using Targeted Next-Generation Sequencing Data [J].

Middha, Sumit ;

Zhang, Liying ;

Nafa, Khedoudja ;

Jayakumaran, Gowtham ;

Wong, Donna ;

Kim, Hyunjae R. ;

Sadowska, Justyna ;

Berger, Michael F. ;

Delair, Deborah F. ;

Shia, Jinru ;

Stadler, Zsofia ;

Klimstra, David S. ;

Ladanyi, Marc ;

Zehir, Ahmet ;

Hechtman, Jaclyn F. .

JCO PRECISION ONCOLOGY, 2017, 1 :1-17

[57] Chromosomal abnormalities and microsatellite instability in sporadic endometrial cancer [J].

Muresu, R ;

Sini, MC ;

Cossu, A ;

Tore, S ;

Baldinu, P ;

Manca, A ;

Pisano, M ;

Loddo, C ;

Dessole, S ;

Pintus, A ;

Tanda, F ;

Palmieri, G .

EUROPEAN JOURNAL OF CANCER, 2002, 38 (13) :1802-1809

[58] Comprehensive molecular characterization of human colon and rectal cancer [J].

Muzny, Donna M. ;

Bainbridge, Matthew N. ;

Chang, Kyle ;

Dinh, Huyen H. ;

Drummond, Jennifer A. ;

Fowler, Gerald ;

Kovar, Christie L. ;

Lewis, Lora R. ;

Morgan, Margaret B. ;

Newsham, Irene F. ;

Reid, Jeffrey G. ;

Santibanez, Jireh ;

Shinbrot, Eve ;

Trevino, Lisa R. ;

Wu, Yuan-Qing ;

Wang, Min ;

Gunaratne, Preethi ;

Donehower, Lawrence A. ;

Creighton, Chad J. ;

Wheeler, David A. ;

Gibbs, Richard A. ;

Lawrence, Michael S. ;

Voet, Douglas ;

Jing, Rui ;

Cibulskis, Kristian ;

Sivachenko, Andrey ;

Stojanov, Petar ;

McKenna, Aaron ;

Lander, Eric S. ;

Gabriel, Stacey ;

Getz, Gad ;

Ding, Li ;

Fulton, Robert S. ;

Koboldt, Daniel C. ;

Wylie, Todd ;

Walker, Jason ;

Dooling, David J. ;

Fulton, Lucinda ;

Delehaunty, Kim D. ;

Fronick, Catrina C. ;

Demeter, Ryan ;

Mardis, Elaine R. ;

Wilson, Richard K. ;

Chu, Andy ;

Chun, Hye-Jung E. ;

Mungall, Andrew J. ;

Pleasance, Erin ;

Robertson, A. Gordon ;

Stoll, Dominik ;

Balasundaram, Miruna .

NATURE, 2012, 487 (7407) :330-337

[59] Predictive and Prognostic Roles of BRAF Mutation in Stage III Colon Cancer: Results from Intergroup Trial CALGB 89803 [J].

Ogino, Shuji ;

Shima, Kaori ;

Meyerhardt, Jeffrey A. ;

McCleary, Nadine J. ;

Ng, Kimmie ;

Hollis, Donna ;

Saltz, Leonard B. ;

Mayer, Robert J. ;

Schaefer, Paul ;

Whittom, Renaud ;

Hantel, Alexander ;

Benson, Al B., III ;

Spiegelman, Donna ;

Goldberg, Richard M. ;

Bertagnolli, Monica M. ;

Fuchs, Charles S. .

CLINICAL CANCER RESEARCH, 2012, 18 (03) :890-900

[60] Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair-Deficient/Microsatellite Instability-High Metastatic Colorectal Cancer [J].

Overman, Michael J. ;

Lonardi, Sara ;

Wong, Ka Yeung Mark ;

Lenz, Heinz-Josef ;

Gelsomino, Fabio ;

Aglietta, Massimo ;

Morse, Michael A. ;

Van Cutsem, Eric ;

McDermott, Ray ;

Hill, Andrew ;

Sawyer, Michael B. ;

Hendlisz, Alain ;

Neyns, Bart ;

Svrcek, Magali ;

Moss, Rebecca A. ;

Ledeine, Jean-Marie ;

Cao, Z. Alexander ;

Kamble, Shital ;

Kopetz, Scott ;

Andre, Thierry .

JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (08) :773-+

← 1 2 3 4 5 6 7 8 →